(0.19%) 5 141.00 points
(0.16%) 38 502 points
(0.26%) 17 892 points
(-0.98%) $83.03
(1.72%) $1.956
(-0.27%) $2 340.90
(0.80%) $27.47
(0.10%) $923.00
(-0.21%) $0.933
(-0.19%) $11.00
(-0.26%) $0.798
(1.10%) $92.89
Live Chart Being Loaded With Signals
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow transplant, cancer, cardiac and cardiology, dermatology, dietetics and clinical nutrition, emergency care, endovascular surgery, endocrinology/diabetes care, ENT, fetal medicine, gastroenterology and hepatology, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedic, pediatric urology and pediatric surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, robotic surgery, spine surgery, transfusion medicine, transplant, and urology and andrology...
Stats | |
---|---|
Šios dienos apimtis | 240 963 |
Vidutinė apimtis | 460 535 |
Rinkos kapitalizacija | 24.80B |
EPS | INR0 ( 2024-02-05 ) |
Kita pelno data | ( INR0 ) 2024-05-20 |
Last Dividend | INR3.00 ( 2023-09-15 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 22.00 |
ATR14 | INR0.326 (0.12%) |
Tūris Koreliacija
Indraprastha Medical Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Indraprastha Medical Koreliacija - Valiuta/Žaliavos
Indraprastha Medical Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR10.99B |
Bruto pelnas: | INR6.25B (56.84 %) |
EPS: | INR9.40 |
FY | 2022 |
Pajamos: | INR10.99B |
Bruto pelnas: | INR6.25B (56.84 %) |
EPS: | INR9.40 |
FY | 2022 |
Pajamos: | INR8.62B |
Bruto pelnas: | INR4.79B (55.55 %) |
EPS: | INR6.39 |
FY | 2021 |
Pajamos: | INR6.13B |
Bruto pelnas: | INR3.65B (59.43 %) |
EPS: | INR0.250 |
Financial Reports:
No articles found.
Indraprastha Medical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR2.50 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR3.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.750 | 2000-12-18 |
Last Dividend | INR3.00 | 2023-09-15 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | INR31.95 | -- |
Avg. Dividend % Per Year | 1.60% | -- |
Score | 2.29 | -- |
Div. Sustainability Score | 4.60 | |
Div.Growth Potential Score | 3.70 | |
Div. Directional Score | 4.15 | -- |
Year | Amount | Yield |
---|---|---|
2000 | INR0 | 0.00% |
2001 | INR0 | 0.00% |
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.500 | 3.10% |
2019 | INR1.600 | 4.06% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR2.50 | 3.18% |
2023 | INR3.00 | 3.61% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TNPETRO.NS | Dividend Junior | 2023-09-18 | Sporadic | 23 | 2.02% | |
PFIZER.NS | Dividend Junior | 2023-08-11 | Annually | 22 | 0.82% | |
JAYBARMARU.NS | Dividend Junior | 2023-09-08 | Annually | 23 | 1.48% | |
DCMSHRIRAM.NS | Dividend Junior | 2023-07-18 | Semi-Annually | 23 | 1.23% | |
SIYSIL.NS | Dividend Junior | 2023-07-24 | Semi-Annually | 18 | 1.37% | |
MEDICAMEQ.NS | Ex Dividend Junior | 2023-09-20 | Annually | 3 | 0.02% | |
GULFOILLUB.NS | Dividend Junior | 2023-08-25 | Annually | 11 | 2.19% | |
BBTC.NS | Dividend Junior | 2023-09-22 | Annually | 22 | 0.08% | |
PRESTIGE.NS | Dividend Junior | 2023-09-14 | Annually | 14 | 0.25% | |
KANSAINER.NS | Dividend Junior | 2023-05-25 | Annually | 21 | 0.49% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0936 | 1.500 | 8.13 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.284 | 1.500 | 7.96 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 44.97 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.67 | 2.00 | 7.11 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 8.67 | 2.00 | 5.67 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.576 | 1.000 | 3.73 | 3.73 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.126 | 1.000 | 9.48 | 9.48 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 21.99 | 1.000 | 7.88 | 0 | [1 - 100] |
returnOnEquityTTM | 0.284 | 2.50 | 8.69 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 8.67 | 2.00 | 7.11 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.110 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.67 | 2.00 | 7.11 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.895 | 1.500 | -9.30 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0660 | 1.000 | -0.849 | 0 | [0.1 - 0.5] |
Total Score | 3.70 |
Indraprastha Medical
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow transplant, cancer, cardiac and cardiology, dermatology, dietetics and clinical nutrition, emergency care, endovascular surgery, endocrinology/diabetes care, ENT, fetal medicine, gastroenterology and hepatology, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedic, pediatric urology and pediatric surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, robotic surgery, spine surgery, transfusion medicine, transplant, and urology and andrology. The company operates cosmetic and dental clinics. Indraprastha Medical Corporation Limited was incorporated in 1988 and is based in New Delhi, India.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.